Jarrett Jennifer
- SEC CIK
- 0001671311
In the past year, 1 open-market purchase filing worth $252.9K and 3 sale filings worth $2.17M.
Current role at each company
- DMRA Damora Therapeutics, Inc.Director, President and CEOas of Sep 28, 2026
- ZURA Zura Bio LtdDirectoras of Jun 22, 2026
- SGMT Sagimet Biosciences Inc.Directoras of Jun 15, 2026
- SNDX Syndax Pharmaceuticals IncDirectoras of Feb 6, 2026
- RCUS Arcus Biosciences, Inc.Chief Operating Officeras of Jan 26, 2026
Show 3 more companies
- Radius Health, Inc.Directoras of Aug 15, 2022
- ARNA Arena Pharmaceuticals IncDirectoras of Mar 11, 2022
- SRZN Surrozen, Inc.Other: Former Directoras of Aug 13, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $252.9K
- 1 filing
- Sold
- $2.17M
- 3 filings
- Net
- −$1.92M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Jarrett Jennifer as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DMRA Damora Therapeutics, Inc.
Director, President and CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2026 (view filing)7:00 AM ET | Sep 25 | 3 days | Jarrett JenniferDirector, President and CEO | PPurchase | +12.5K | $20.23 | +$252.9K | +2.5%512.5K after |
RCUS Arcus Biosciences, Inc.
Chief Operating Officer20 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2021 (view filing) | Sep 20-21 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −47.5K | $35.35 | −$1.68M | −29.6%112.8K after | 5 lots |
| Dec 20, 2021 (view filing) | Dec 16-17 | 4 days | Jarrett JenniferChief Operating Officer | SSale | −12.7K | $40.12 | −$508.7K | −9.2%125.4K after | 6 lots |
| Dec 22, 2021 (view filing) | Dec 20 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −34.8K | $41.48 | −$1.44M | −27.8%90.6K after | 3 lots |
| Mar 18, 2022 (view filing) | Mar 16 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −9.62K | $31.62 | −$304.1K | −8.3%106.0K after | |
| Jun 21, 2022 (view filing) | Jun 16-17 | 5 days | Jarrett JenniferChief Operating Officer | SSale | −12.7K | $21.45 | −$272.3K | −9.7%118.6K after | 3 lots |
| Sep 20, 2022 (view filing) | Sep 16 | 4 days | Jarrett JenniferChief Operating Officer | SSale | −12.7K | $26.28 | −$333.2K | −8.8%130.9K after | |
| Dec 16, 2022 (view filing) | Dec 16 | Same day | Jarrett JenniferChief Operating Officer | SSale | −16.5K | $30.75 | −$506.8K | −10.0%147.6K after | 2 lots |
| Jan 30, 2023 (view filing) | Jan 26-27 | 4 days | Jarrett JenniferChief Operating Officer | SSale | −1.90K | $23.53 | −$44.7K | −0.5%414.9K after | 2 lots |
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Jarrett JenniferChief Operating Officer | SSale | −8.73K | $16.81 | −$146.7K | −2.1%406.2K after | |
| Jun 16, 2023 (view filing) | Jun 16 | Same day | Jarrett JenniferChief Operating Officer | SSale | −12.6K | $19.35 | −$243.1K | −3.1%394.0K after | 10b5-1 |